Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 9/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.43 |
| ▸ | LMNA | P02545 | 4/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 8/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.39 |
| ▸ | MYOC | Q99972 | 1/20 | 0.39 |
| ▸ | HTR1E | P28566 | 2/20 | 0.39 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.39 |
| ▸ | CRHBP | P24387 | 1/20 | 0.37 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9839725 | 0.98 | MEN1 (0.44) | MEN1KMT2ALMNASMN1; SMN2HPGD | |
| SCHEMBL8330156 | 0.94 | MEN1 (0.39) | MEN1KMT2ALMNASMN1; SMN2HPGD | |
| SCHEMBL5943202 | 0.87 | SSTR3 (0.45) | MEN1KMT2ASMN1; SMN2MAPTNPC1 | |
| SCHEMBL3314831 | 0.83 | TACR1 (0.41) | MEN1KMT2ALMNASMN1; SMN2HPGD | |
| SCHEMBL8351160 | 0.83 | MMP1 (0.45) | MEN1KMT2AMAPT | |
| SCHEMBL4898719 | 0.79 | TACR1 (0.41) | MEN1KMT2ALMNASMN1; SMN2HPGD | |
| SCHEMBL3926322 | 0.78 | TACR1 (0.41) | LMNASMN1; SMN2HPGD | |
| SCHEMBL1078320 | 0.76 | TACR1 (0.42) | MEN1KMT2ASMN1; SMN2HPGD | |
| SCHEMBL1651305 | 0.75 | KMT2A (0.53) | MEN1KMT2ALMNASMN1; SMN2MAPT | |
| SCHEMBL3513112 | 0.75 | FKBP4 (0.44) | SMN1; SMN2HPGDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5073487-A | Rapid assay for functional human α1 -proteinase inhibitor | ATHENS RESEARCH AND TECHNOLOGY, INC. (US) | 1991-12-17 | — | — | US | claimed |
| EP-0455733-A1 | RAPID ASSAY FOR FUNCTIONAL HUMAN ALPHA 1?-PROTEINASE INHIBITOR | ATHENS RESEARCH AND TECHNOLOGY, INC. (US) | 1991-11-13 | — | — | EP | claimed |
| WO-1990008837-A1 | RAPID ASSAY FOR FUNCTIONAL HUMAN ALPHA1-PROTEINASE INHIBITOR | ATHENS RESEARCH AND TECHNOLOGY, INC. (US) | 1990-08-09 | — | — | WO | claimed |
| CN-106456492-B | The purposes of Pigments of Fruit of Japanese Rose compound | 三得利控股株式会社 | 2019-09-24 | — | — | CN | disclosed |
| WO-2019177982-A1 | METHODS AND COMPOSTIONS FOR ALPHA-1 ANTITRYPSIN RELATED DISEASE DISORDERS | PROTEASE PHARMACEUTICALS INC. (US) | 2019-09-19 | — | — | WO | disclosed |
| EP-3386596-A1 | TOPICAL SKIN CARE COMPOSITIONS COMPRISING MYRSINE AFRICANA EXTRACTS | University Of Pretoria (ZA) | 2018-10-17 | — | — | EP | disclosed |
| US-20180092964-A1 | LDL QUANTITATION AND METHODS OF USE | BRISTOW CYNTHIA L (US) | 2018-04-05 | — | — | US | disclosed |
| US-20180003699-A1 | Therapeutic Use for Alpha1 Proteinase Inhibitor in Hematopoiesis | THE INSTITUTE FOR HUMAN GENETICS AND BIOCHEMISTRY | 2018-01-04 | — | — | US | disclosed |
| WO-2017098426-A1 | TOPICAL SKIN CARE COMPOSITIONS COMPRISING MYRSINE AFRICANA EXTRACTS | UNIVERSITY OF PRETORIA (ZA) | 2017-06-15 | — | — | WO | disclosed |
| US-9612233-B2 | Therapeutic use for ALPHA1 proteinase inhibitor in hematopoiesis | THE INSTITUTE FOR HUMAN GENETICS AND BIOCHEMISTRY (US) | 2017-04-04 | — | — | US | disclosed |
| CN-106456492-A | Novel use of rose dye compound | 三得利控股株式会社 | 2017-02-22 | — | — | CN | disclosed |
| EP-0770876-A1 | A screening method for identifying ligands for target proteins | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 1997-05-02 | — | — | EP | disclosed |
| WO-1995029189-A1 | FACTOR Xa INHIBITORS | SELECTIDE CORPORATION (US) | 1995-11-02 | — | — | WO | disclosed |
| US-5212068-A | Genetic engineering, biosynthesis | SANKYO COMPANY LIMITED (JP) | 1993-05-18 | — | — | US | disclosed |
| US-5073487-A | Rapid assay for functional human α1 -proteinase inhibitor | ATHENS RESEARCH AND TECHNOLOGY, INC. (US) | 1991-12-17 | — | — | US | disclosed |
| EP-0455733-A1 | RAPID ASSAY FOR FUNCTIONAL HUMAN ALPHA 1?-PROTEINASE INHIBITOR | ATHENS RESEARCH AND TECHNOLOGY, INC. (US) | 1991-11-13 | — | — | EP | disclosed |
| US-4985361-A | GENETIC ENGINEERING | SANKYO COMPANY, LIMITED (JP) | 1991-01-15 | — | — | US | disclosed |
| EP-0198645-B1 | HUMAN PANCREATIC ELASTASE | SANKYO COMPANY LIMITED (JP) | 1990-11-22 | — | — | EP | disclosed |
| WO-1990008837-A1 | RAPID ASSAY FOR FUNCTIONAL HUMAN ALPHA1-PROTEINASE INHIBITOR | ATHENS RESEARCH AND TECHNOLOGY, INC. (US) | 1990-08-09 | — | — | WO | disclosed |
| EP-0198645-A1 | Human pancreatic elastase | SANKYO COMPANY LIMITED (JP) | 1986-10-22 | — | — | EP | disclosed |